DNA-based sensors for live-cell mapping of metabolite- and metal ion-protein interactions

Background

Understanding how metabolites and metal ions interact with proteins inside living cells is essential for decoding cellular signaling, metabolic regulation, and disease mechanisms. These small molecules function as cofactors, second messengers, and allosteric regulators, orchestrating critical pathways that govern cell behavior. However, traditional biochemical methods often rely on lysate-based assays that disrupt native spatial organization and lose transient or low-affinity interactions, creating significant gaps in our knowledge of dynamic cellular processes.

Existing interactome mapping approaches—such as affinity purification-mass spectrometry and enzyme-mediated proximity labeling—face notable limita­tions. Lysate-based workflows destroy subcellular localization and under­represent fast or labile interactions. Genetically encoded tags used in enzyme-based methods are bulky and difficult to apply in primary cells or tissues, and small-molecule probes frequently suffer from off-target effects and inefficient intracellular delivery. Moreover, slow reaction kinetics limit the capture of transient biological events, making it difficult to fully map metabolite and metal ion signaling under physiological conditions.

Technology overview

This technology introduces functional DNA-based sensors that use aptamers or DNAzymes engineered to carry a sulfonyl fluoride (SuFEx) electrophile at the 2′ sugar position. In their resting state, the electrophile is sequestered within a stable DNA duplex, preventing premature activation. Upon binding a specific intracellular metabolite or metal ion, a conformational change exposes the SuFEx group, triggering proximity-based covalent labeling of proteins near the target pool.

The labeled proteins are subsequently identified and quantified via quantitative proteomics, all without requiring cell lysis or disrupting cellular organization. Demonstrated for ATP and sodium ions (Na⁺), the platform provides high spatial and temporal resolution of dynamic interactomes in living cells. Its modular architecture allows rapid substitution of DNA sensors to adapt to different biological targets, and ongoing improvements in delivery and reaction kinetics further enhance its utility for diverse biological systems.

Benefits

  • Enables live-cell, spatially resolved mapping of metabolite- and metal ion-protein interactions
  • Activates covalent labeling only upon target binding, minimizing off-target effects
  • SuFEx chemistry ensures stable, specific covalent linkages for down­stream proteomic analysis
  • Modular platform easily adapts to different metabolites or ions by swapping DNA sensors
  • Compatible with live tissues and primary cells without the need for genetic modification

Commercial applications

  • Mapping dynamic intracellular interactomes for metabolites and metal ions
  • Studying signaling networks and metabolic regulation in live cells
  • Drug target identification and validation
  • Systems biology and pathway discovery in native physiological environments
  • Diagnostic tool development for metabolic and ion dysregulation diseases

Opportunity

  • Overcomes the spatial, temporal, and specificity limitations of conventional interactome mapping techniques
  • Provides a flexible, scalable platform for studying complex cellular networks in living systems
  • Available for licensing to partners in proteomics, chemical biology, diagnostics, and therapeutic discovery

Intellectual property

  • US application 19/080,132

 

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Mapping Metabolite- and Metal Ion-Protein Interactomes Using Functional DNA-based Proximity Labeling Utility (Conversion) United States 19/080,132   3/14/2025